Friday, 13 December 2013: 10:55 - 11:15
Great Lakes Grand Ballroom East (Westin - Michigan Avenue)
Stephen T. Holgate
,
Clinical & Experimental Sciences Academic Unit, University of Southampton, Southampton, United Kingdom
Learning Objectives:
Illustrate the rationale of IgE blockade in the treatment of allergic disease.
Illustrate the rationale of IgE blockade in the treatment of allergic disease.
Analyze the benefits and indications of anti-IgE monoclonal antibody (omalizumab) in asthma and which of these patients might benefit most from omalizumab.